These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26514537)

  • 1. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer.
    Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
    Asian Pac J Cancer Prev; 2015; 16(16):7359-63. PubMed ID: 26514537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model.
    Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
    Asian Pac J Cancer Prev; 2015; 16(18):8567-71. PubMed ID: 26745118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.
    Baghestani AR; Shahmirzalou P; Sayad S; Akbari ME; Zayeri F
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1601-1606. PubMed ID: 29936785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.
    Baghestani AR; Zayeri F; Akbari ME; Shojaee L; Khadembashi N; Shahmirzalou P
    Asian Pac J Cancer Prev; 2015; 16(17):7923-7. PubMed ID: 26625822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the cure rate in Iranian breast cancer patients.
    Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of prognostic factors in long-term survival of male and female patients with colorectal cancer using non-mixture cure model based on the Weibull distribution.
    Azizmohammad Looha M; Zarean E; Masaebi F; Pourhoseingholi MA; Zali MR
    Surg Oncol; 2021 Sep; 38():101562. PubMed ID: 33862578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.
    Meshkat M; Baghestani AR; Zayeri F; Khayamzadeh M; Akbari ME
    Breast J; 2018 Nov; 24(6):1015-1018. PubMed ID: 30270522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing Survival Rate of Leukemia Patients Applying Long Term Exponential Model.
    Faridizadeh M; Alavi Majd H; Parkhideh S; Hajifathali A; Raei M; Ramezani N; Saeedi A; Baghestani AR
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1539-1543. PubMed ID: 32592346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
    Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
    Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.
    Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
    Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
    J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival in patients with breast cancer referred to Cancer Research Center in Iran.
    Baghestani AR; Shahmirzalou P; Zayeri F; Akbari ME; Hadizadeh M
    Asian Pac J Cancer Prev; 2015; 16(12):5081-4. PubMed ID: 26163645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic analysis in a Chinese population with T1-2N1 breast cancer: Did patients with 1 or 2, and 3 positive axillary lymph nodes have similar survival outcomes?
    Shen H; Yuan J; Yang Y; Liu X; Wang L; Feng X; Zhao L; Niu Y
    J Surg Oncol; 2015 Nov; 112(6):569-74. PubMed ID: 26458282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
    Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
    Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring factors related to metastasis free survival in breast cancer patients using Bayesian cure models.
    Jafari-Koshki T; Mansourian M; Mokarian F
    Asian Pac J Cancer Prev; 2014; 15(22):9673-8. PubMed ID: 25520087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
    Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement.
    Shigematsu H; Taguchi K; Koui H; Ohno S
    Ann Surg Oncol; 2015 Jul; 22(7):2365-71. PubMed ID: 25476029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type of breast cancer diagnosis, screening, and survival.
    Cedolini C; Bertozzi S; Londero AP; Bernardi S; Seriau L; Concina S; Cattin F; Risaliti A
    Clin Breast Cancer; 2014 Aug; 14(4):235-40. PubMed ID: 24703317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cure models for estimating hospital-based breast cancer survival.
    Rama R; Swaminathan R; Venkatesan P
    Asian Pac J Cancer Prev; 2010; 11(2):387-91. PubMed ID: 20843121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
    PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.